Charles River Labs Intl buy JPMorgan Chase & Co.
Start price
10.08.23
/
50%
€198.20
Target price
10.08.24
€227.00
Performance (%)
-7.39%
End price
11.08.24
€183.55
Summary
This prediction ended on 11.08.24 with a price of €183.55. With a performance of -7.39%, the BUY prediction by JPMorgan_Chase___Co_ finished with a loss. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | -1.901% | -1.901% | 16.016% |
| iShares Core DAX® | -1.764% | 2.259% | 15.213% |
| iShares Nasdaq 100 | -1.632% | -0.193% | 3.293% |
| iShares Nikkei 225® | -2.451% | 4.086% | 17.198% |
| iShares S&P 500 | -2.252% | -0.151% | 0.574% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at JPMorgan Chase & Co. from $225.00 to $250.00. They now have an "overweight" rating on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€227.80
15.02.24
15.02.24
€259.70
15.02.25
15.02.25
-36.02%
16.02.25
16.02.25
Charles River Labs Intl
Start price
Target price
Perf. (%)
€211.90
20.12.23
20.12.23
€246.65
20.12.24
20.12.24
-15.24%
21.12.24
21.12.24